Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
about
A Novel Type of Non-coding RNA, nc886, Implicated in Tumor Sensing and SuppressionIndividual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsCombination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis.Tumor surveillance by circulating microRNAs: a hypothesis.miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.MicroRNA expression profiling in male and female familial breast cancer.Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A.MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.miRNome of inflammatory breast cancer.miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal AdenocarcinomamicroRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsTissue specific expression of extracellular microRNA in human breast cancers and normal human breast tissue in vivo.Controlled ovarian hyperstimulation induced changes in the expression of circulatory miRNA in bovine follicular fluid and blood plasma.MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma.nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer.miR-134: A Human Cancer Suppressor?Epithelial-mesenchymal transition transcription factors and miRNAs: "Plastic surgeons" of breast cancerDifferential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells.miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway.Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.Enhancing identification of cancer types via lowly-expressed microRNAs.Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.Are Circulating microRNAs Involved in Tumor Surveillance?Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity.miR-497 expression, function and clinical application in cancer.MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women.miRNAs as Biomarkers for Predicting the Progression of Ductal Carcinoma in Situ.The clinical value of miR-193a-3p in non-small cell lung cancer and its potential molecular mechanism explored in silico using RNA-sequencing and microarray data.MicroRNA Networks in Breast Cancer Cells.miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
P2860
Q26801690-0E6F0B9B-4D81-4034-A937-5644D07CDA25Q28302352-E31EDAF6-48C2-4AC6-A903-C5EAEFD9D47FQ33850249-45C570C3-A672-4B21-AB06-6085A72ADDC7Q34324228-2100D161-2AE2-4449-AF77-A16271F63D03Q34355302-AC907539-2BA2-463B-B706-845A40B8E32DQ34687031-5FAF23BE-0621-47F5-A31F-07E33BFAC4F2Q34733033-671E3D2A-C4CE-45BC-BA33-4F216326EBB6Q34834106-2E24E407-4BF1-4E52-81A5-830C281B74E1Q34896961-60FA6F29-E0CE-4A71-9855-99B9424B964EQ34958888-8EC03705-2E4F-4031-A8DD-454083F07F6DQ35203269-670C197F-70BA-4827-8F81-A01FA46A5D7EQ35852437-4C480946-5B37-4333-B0FE-F6E7B8746599Q35942943-17DEDAF4-CF4B-4B31-B4F9-B2697AF2B3E0Q35955244-CF665672-85D9-4914-93FA-CF3D8EA70EF8Q36356125-282685EF-DD5B-40AB-97DE-0A2DF61B32A3Q36357957-9A3C3F0F-1050-4F9A-B47F-6525CAA15FD8Q36428863-55BD8711-12A5-482C-875A-40C2F26FD2FEQ36544789-1EC0560C-54D6-496D-B44E-914A1A6CC4E0Q36706415-14B695A5-54BC-45A1-B476-611DBC38221EQ37085896-4286E9CD-7F57-4EEA-9757-9B4D34C813E4Q37577131-E846A00A-0DEA-4EF4-A8DA-FFBEFA1B6076Q37688884-AC5EE0FB-BBE7-4AD6-8B61-3939F72D0E45Q37718061-CBE2D47D-A475-4C92-90ED-4955BC72F81DQ38239141-1FFB4529-6D05-4CD2-89CA-14C42C76F91AQ38620609-8DEC7EC1-D110-432E-BA8B-5E74132A9859Q38710752-2C28D4F5-DB9F-4B59-8EFD-BB613F7CB8ACQ38807433-EFB5300C-FB24-4D91-AB17-96A71D8FD17DQ38819255-A473A998-83D8-4EC0-8711-430C79CAAF52Q38853181-8892810F-8215-4BB3-B4A3-5EEB3ED5622BQ38987546-77BC1435-B98B-4175-BE9B-DF88EC962610Q40274014-4C725125-DD57-4B04-8674-92CAE6FE57C1Q40965602-3C104C2C-5F91-43DA-9B8D-B35DFB514819Q41342922-A4DD2982-4A62-42F0-B7BA-88FDFA7A227FQ42317497-5F72C4D1-1281-4418-934A-B88E6D95BB94Q42706828-197A3264-1CCF-4E5C-9095-0BC02ADFAC82Q46013493-A7B6C8CB-D478-49A7-A2BF-E6234C93F752Q47778954-A92F5F66-12DD-419E-9FD6-3C5406DC96D5Q49182439-3E0EA428-8F13-46B2-BD83-52C107AE4763Q49979472-81E5602C-8B2D-40D3-B271-A61074B909CEQ50592086-4C28D084-6424-4963-90BE-D9CEFE21F8E8
P2860
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Deregulation of cancer-related ...... malignant human breast tumors.
@en
Deregulation of cancer-related ...... malignant human breast tumors.
@nl
type
label
Deregulation of cancer-related ...... malignant human breast tumors.
@en
Deregulation of cancer-related ...... malignant human breast tumors.
@nl
prefLabel
Deregulation of cancer-related ...... malignant human breast tumors.
@en
Deregulation of cancer-related ...... malignant human breast tumors.
@nl
P2093
P50
P356
P1433
P1476
Deregulation of cancer-related ...... malignant human breast tumors.
@en
P2093
Andliena Tahiri
Ida R K Bukholm
Israel Steinfeld
Jürgen Geisler
Margit L H Riis
Miriam Ragle Aure
Rami Mäkelä
Silje Nord
Zohar Yakhini
P356
10.1093/CARCIN/BGT333
P407
P50
P577
2013-10-08T00:00:00Z